<DOC>
	<DOCNO>NCT02767505</DOCNO>
	<brief_summary>This nationwide registry-based randomized clinical multicenter trial patient randomize gastric bypass ( RYGB ) sleeve gastrectomy ( SG ) . The co-primary endpoint weight control 5 year amount severe adverse event . Additionally investigator predefined number secondary endpoint , trial sufficient number patient allow comparison across subgroup .</brief_summary>
	<brief_title>Bypass Equipoise Sleeve Trial ( BEST )</brief_title>
	<detailed_description>Follow-up patient use routine respectively regular follow-up Scandinavian Obesity Surgery Registry ( SOReg ) 6v , 1 year , 2 year , 5 year . In order evaluate SG advantage compare previous standard , investigator want examine whether SG operation equivalent ( non-inferiority ) weight loss weight stability five year surgery comparison GBP , SG associate few long-term complication ( superiority ) . The primary outcome measure emanate assessment long term weight management frequency serious complication .</detailed_description>
	<mesh_term>Obesity , Morbid</mesh_term>
	<criteria>BMI 3550 kg/m2 Ability understand decide merit study participation Accepted bariatric surgery Previous bariatric surgery , antireflux surgery gastric surgery Moderate severe reflux disease know hiatus hernia &gt; 4 cm Planned significant surgery time Inflammatory bowel disease ongoing drug substance abuse appropriate randomize patient , accord surgeon</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>